Literature DB >> 24857758

Effect of quercetin and rutin in some acute seizure models in mice.

Dorota Nieoczym1, Katarzyna Socała2, Grzegorz Raszewski3, Piotr Wlaź2.   

Abstract

Quercetin is one of the most widely occurring flavonoid which is also often present in plants as glycosidic form - rutin. These compounds are ingredients of plant diet and are also present in numerous pharmaceutical preparations and diet supplements which are taken by patients suffering from epilepsy and treating with antiepileptic drugs (AEDs). Influence of these compounds on central nervous system-related effects was proved both in experimental and clinical studies. Their influence on anxiety, depression, memory processes and convulsant activity was reported. The aim of the present study was to investigate the effect of quercetin and rutin in some models of seizures, i.e., in the model of psychomotor seizures induced by 6Hz stimulation, in the maximal electroshock seizure threshold and intravenous pentylenetetrazole tests in mice. We also examined a possible mechanism of anticonvulsant activity of quercetin and its influence on action of two AEDs, i.e., valproic acid and levetiracetam, in the 6Hz seizure test. Our results revealed only a weak anticonvulsant potential of the studied flavonoids because they showed anticonvulsant action at doses from 10 to 200mg/kg only in the 6Hz test and did not change seizure thresholds in the remaining tests. Moreover, anticonvulsant action of the studied flavonoids was short-term, noted only at pretreatment time ranging between 30 and 60min. The highest anticonvulsant activity of quercetin was correlated with its high plasma and brain concentration, which was revealed in a pharmacokinetic study. We did not note changes in the anticonvulsant action of the used AEDs combined with quercetin in the model of psychomotor seizures in mice. Neither quercetin and rutin nor combinations of quercetin with the studied AEDs produced any significant impairments of motor coordination (assessed in the chimney test), muscular strength (investigated in the grip-strength test) and long-term memory (evaluated in the passive avoidance test) in mice. The results of the present study suggest that quercetin and rutin have only weak and short-term anticonvulsant potential. These flavonoids seem to be safe for patients with epilepsy because they neither changed activity of the studied AEDs nor produced any adverse effects.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiepileptic drugs; Mice; Quercetin; Rutin; Seizure models

Mesh:

Substances:

Year:  2014        PMID: 24857758     DOI: 10.1016/j.pnpbp.2014.05.007

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  18 in total

1.  The effects of quercetin on the gene expression of the GABAA receptor α5 subunit gene in a mouse model of kainic acid-induced seizure.

Authors:  Sahar Moghbelinejad; Safar Alizadeh; Ghazaleh Mohammadi; Fatemeh Khodabandehloo; Zahra Rashvand; Reza Najafipour; Marjan Nassiri-Asl
Journal:  J Physiol Sci       Date:  2016-10-14       Impact factor: 2.781

2.  Ameliorating effect of quercetin on acute pentylenetetrazole induced seizures in rats.

Authors:  Fatih Sefil; Ibrahim Kahraman; Recep Dokuyucu; Hasan Gokce; Atakan Ozturk; Okan Tutuk; Mehmet Aydin; Umit Ozkan; Neslihan Pinar
Journal:  Int J Clin Exp Med       Date:  2014-09-15

3.  Molecular mechanisms involved in the prevention and reversal of ketamine-induced schizophrenia-like behavior by rutin: the role of glutamic acid decarboxylase isoform-67, cholinergic, Nox-2-oxidative stress pathways in mice.

Authors:  Tolulope Olabode Oshodi; Benneth Ben-Azu; Ismail O Ishola; Abayomi Mayowa Ajayi; Osagie Emokpae; Solomon Umukoro
Journal:  Mol Biol Rep       Date:  2021-04-03       Impact factor: 2.316

4.  Development and validation of a reverse phase HPLC-DAD method for separation, detection & quantification of rutin and quercetin in buckwheat (Fagopyrum spp.).

Authors:  Sabbi Jan; Javaid Ahmad; Mohd Masarat Dar; Aijaz A Wani; Inayatullah Tahir; Azra N Kamili
Journal:  J Food Sci Technol       Date:  2021-11-29       Impact factor: 3.117

Review 5.  Therapeutic Potential of Quercetin and its Derivatives in Epilepsy: Evidence from Preclinical Studies.

Authors:  Chandra Prakash; Jyoti Tyagi; Shyam Sunder Rabidas; Vijay Kumar; Deepak Sharma
Journal:  Neuromolecular Med       Date:  2022-08-11       Impact factor: 4.103

Review 6.  The Genus Alternanthera: Phytochemical and Ethnopharmacological Perspectives.

Authors:  Rajeev K Singla; Vivek Dhir; Reecha Madaan; Deepak Kumar; Simranjit Singh Bola; Monika Bansal; Suresh Kumar; Ankit Kumar Dubey; Shailja Singla; Bairong Shen
Journal:  Front Pharmacol       Date:  2022-04-11       Impact factor: 5.988

7.  An up-to-date review of rutin and its biological and pharmacological activities.

Authors:  Naif Abdullah Al-Dhabi; Mariadhas Valan Arasu; Chang Ha Park; Sang Un Park
Journal:  EXCLI J       Date:  2015-01-09       Impact factor: 4.068

8.  The effects of naloxone, diazepam, and quercetin on seizure and sedation in acute on chronic tramadol administration: an experimental study.

Authors:  Samaneh Nakhaee; Khadijeh Farrokhfall; Ebrahim Miri-Moghaddam; Mohsen Foadoddini; Masoumeh Askari; Alireza Amirabadizadeh; Jeffrey Brent; Bruno Megarbane; Omid Mehrpour
Journal:  Behav Brain Funct       Date:  2021-05-29       Impact factor: 3.759

Review 9.  Neuropharmacological Effects of Quercetin: A Literature-Based Review.

Authors:  Md Shahazul Islam; Cristina Quispe; Rajib Hossain; Muhammad Torequl Islam; Ahmed Al-Harrasi; Ahmed Al-Rawahi; Miquel Martorell; Assem Mamurova; Ainur Seilkhan; Nazgul Altybaeva; Bagila Abdullayeva; Anca Oana Docea; Daniela Calina; Javad Sharifi-Rad
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

10.  α-Spinasterol, a TRPV1 receptor antagonist, elevates the seizure threshold in three acute seizure tests in mice.

Authors:  Katarzyna Socała; Dorota Nieoczym; Mateusz Pieróg; Piotr Wlaź
Journal:  J Neural Transm (Vienna)       Date:  2015-03-13       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.